VolitionRx Limited (NYSE:NYSE:VNRX) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM Company Participants Scott Powell - IR Cameron Reynolds - Founder, Group CEO Tom Butera - CEO,.
/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the third quarter ended.
/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the third quarter ended.